MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 139 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,525,000 | +5.2% | 12,173 | -5.3% | 0.00% | 0.0% |
Q4 2018 | $1,449,000 | -74.4% | 12,855 | -51.3% | 0.00% | -50.0% |
Q3 2018 | $5,654,000 | +58.3% | 26,406 | +106.8% | 0.00% | 0.0% |
Q2 2018 | $3,571,000 | +280.3% | 12,769 | +58.8% | 0.00% | +100.0% |
Q1 2018 | $939,000 | -57.7% | 8,042 | -66.8% | 0.00% | 0.0% |
Q4 2017 | $2,220,000 | +493.6% | 24,189 | +191.3% | 0.00% | – |
Q3 2017 | $374,000 | +211.7% | 8,304 | +12.9% | 0.00% | – |
Q2 2017 | $120,000 | – | 7,354 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |